3 March 2024
DBL Pharmaceuticals Ltd. convened its highly anticipated 2nd Annual Business Conference at the prestigious Hotel Sea Palace. The event served as a pivotal moment for DBL Pharma, rallying its dedicated field force around a shared commitment to delivering unparalleled quality and innovative medicines to humanity.
The conference was inaugurated by Mr. Abdul Wahed, Chairman, DBL Group, whose insightful address encapsulated the remarkable journey and achievements of the DBL Group across diverse industries. Expressing optimism, Mr. Wahed underscored the potential for DBL Pharma to carve out a prominent position within the pharmaceutical landscape.
A highlight of the conference was the presence of Mr. Md. Hassan Imam, Director and elder son of Chairman of DBL Group. Mr. Imam graced the occasion with his presence and presided over the ceremony to honor the best performers of DBL Pharma of 2023. His presence added a touch of prestige, reinforcing DBL Pharma’s commitment to recognizing and rewarding excellence within its ranks.
Mr. Ahmed Kamrul Alam, Executive Director, Business Operations, captivated the audience with a compelling narrative of DBL Pharma’s successes throughout 2023 and articulated ambitious future goals, setting the tone for the company’s trajectory.
Addressing the challenges of the past year and charting a resilient path forward, Head of Sales and Marketing Managers shared their valuable insights on overcoming obstacles, fostering an environment of adaptability and growth.
We were honored to have the presence of our Site Head, Chief Financial Officer, Chief HR Officer-DBL Group, and all other corporate managers at this event, making it a truly memorable occasion.
The 2nd Annual Business Conference not only served as a platform to reflect on past achievements but also as a catalyst for DBL Pharma’s continued evolution towards excellence in the pharmaceutical realm. With unwavering determination and a clear vision, DBL Pharma remains steadfast in its mission to elevate healthcare standards and make a meaningful impact on society.
DBL pharma recently unveiled Seretrol-F Sykonahaler, which is a technologically advanced Multi-Dose Dry Powder Inhaler. This device will ensure precise treatment for the management of Asthma & COPD and overcome the limitation of the conventional devices. The grand launching event is endorsed by Bangladesh Lung Foundation (BLF) and held at Sheraton Banani, Dhaka on 05… Continue reading DBL pharma launches Seretrol-F Sykonahaler
DBL Pharmaceuticals Ltd. convened its highly anticipated 2nd Annual Business Conference at the prestigious Hotel Sea Palace. The event served as a pivotal moment for DBL Pharma, rallying its dedicated field force around a shared commitment to delivering unparalleled quality and innovative medicines to humanity. The conference was inaugurated by Mr. Abdul Wahed, Chairman, DBL… Continue reading DBL Pharma Hosts 2nd Annual Business Conference
DBL Pharma celebrates 3rd Annual Business Conference with Vision to Victory
DBL Pharmaceuticals Ltd. hosted its 3rd Annual Business Conference on January 11, 2025, at Cox’s Bazar. The event brought together the company’s sales & marketing team along with key stakeholders to discuss its mission of providing high-quality and innovative medicines for better healthcare. The Board of Directors including Chairman Mr. Abdul Wahed, Managing Director Mr.… Continue reading DBL Pharma celebrates 3rd Annual Business Conference with Vision to Victory